[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Spontonic posts on X about $chrs, $pfe, $mrk, $4507t the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence stocks XXXXX%
Social topic influence $chrs 17.65%, $pfe 11.76%, $mrk 11.76%, $4507t 5.88%, $cmpx 5.88%, sanofi 5.88%, supreme court XXXX%
Top accounts mentioned or mentioned by @qniatof @chrisintroy
Top assets mentioned Pfizer, Inc. (PFE) Merck & Co., Inc. (MRK) Sanofi (SNY)
Top posts by engagements in the last XX hours
"#CCR8 Shimon Sakaguchi and the Nobel Prize in Physiology or Medicine 2025. among other accomplishments"
X Link @spontonic 2025-10-06T20:58Z XXX followers, XXX engagements
"Anti-#CCR8 MAb S-531011 Shionogi"
X Link @spontonic 2025-10-07T21:07Z XXX followers, XXX engagements
"3/ For example $PFE knows how much it needs a good CCR8. Dias et al. have been quick and bright $CHRS is in the mix. So. co-develop XXX exclusive. send that tori salesforce out to sell that An aside. STORM has venture ties with PFE"
X Link @spontonic 2025-08-08T01:19Z XXX followers, XXX engagements
"$CHRS $PFE $MRK $CMPX More on companies that need CHS-114. "It hardly needs stating that biopharma has staked huge sums on PD-(L)1 x VEGF bispecifics". All of the molecules mentioned will need life extension plans"
X Link @spontonic 2025-08-13T16:19Z XXX followers, XXX engagements
"Merck's footprints. clinical trial supply agreements (that won't look remotely practical to most potential partners) And the BOD does nothing. $CHRS $MRK"
X Link @spontonic 2025-08-14T21:21Z XXX followers, XXX engagements
"Sort of figured. But of course AI agents do make mistakes and can't predict a future shaped by existing but unforeseen biology. Junshi attempting to use tori's own Fab to cut into its partner's sales"
X Link @spontonic 2025-10-17T18:21Z XXX followers, XX engagements
"Amgen v. Sanofi: The 2023 Supreme Court ruling in Amgen v. Sanofi affirmed the need for patents to sufficiently enable the full scope of a claimed invention reinforcing the idea that broad speculative claims are not valid. By analogy a license"
X Link @spontonic 2025-10-17T18:26Z XXX followers, XX engagements